Summary
Gilead Sciences, Inc. (GILD) announced the appointment of Javier J. Rodriguez to its Board of Directors, effective June 15, 2020. Mr. Rodriguez's appointment is a standard addition to the board and does not involve any disclosed related party transactions or special compensation arrangements outside of the company's regular non-employee director compensation programs. Mr. Rodriguez will receive compensation for his service, which includes a pro-rated equity grant consisting of stock options and restricted stock units, as well as a pro-rated cash retainer. This appointment signifies a routine governance update for Gilead, aimed at strengthening its board oversight.
Key Highlights
- 1Javier J. Rodriguez appointed to Gilead's Board of Directors, effective June 15, 2020.
- 2No disclosed arrangements or understandings between Mr. Rodriguez and other parties regarding his selection.
- 3No reportable related party transactions involving Mr. Rodriguez.
- 4Mr. Rodriguez will receive standard compensation for non-employee directors.
- 5Equity compensation includes a pro-rated grant of 8,667 stock options and 1,838 restricted stock units.
- 6Cash compensation includes a pro-rated retainer of $3,287.67 for service through June 30, 2020.
- 7Details on director compensation and the equity plan are available in the company's proxy statement and prior 8-K filing.